小RNA
未折叠蛋白反应
生物
程序性细胞死亡
细胞凋亡
生物信息学
细胞生物学
计算生物学
内质网
基因
遗传学
作者
Mahdieh Azizi,Sadra Salehi-Mazandarani,Parvaneh Nikpour,Alireza Andalib,Marzieh Rezaei
出处
期刊:Life Sciences
[Elsevier BV]
日期:2022-12-29
卷期号:314: 121341-121341
被引量:9
标识
DOI:10.1016/j.lfs.2022.121341
摘要
Immunogenic cell death (ICD) is a type of cellular death that is elicited in response to the specific types of anti-cancer therapies and enhances the anti-tumor immune responses by the combination of antigenicity and adjuvanticity of dying tumor cells. There is a well-established interlink between endoplasmic reticulum stress (ERS) and ICD elicited by anti-cancer therapies. Most recent evidences support that unfolded protein response (UPR)-associated miRNAs can be key players in the ERS-induced ICD. Hence, in the present study, we conducted a literature review on the role of these miRNAs and associated molecular pathways that may regulate ICD. We first collected UPR-associated miRNAs that promote ERS-induced apoptosis and then focused on microRNAs (miRNAs) that promote ERS-induced apoptosis via PERK/eIF2α/ATF4/CHOP pathway activation, as the main core for ICD and release of damage-associated molecular patterns. To better identify PERK/eIF2α/ATF4/CHOP pathway-inducing miRNAs that can be used as potential therapeutic targets for improving ICD in cancer treatment, we did a comprehensive bioinformatics analysis and network construction. Our results showed that “pathways in cancer”, “MAPK signaling pathway”, “PI3K-Akt signaling pathway”, and “Cellular senescence”, which correlate with UPR components and ERS induction, were among the significant signaling pathways related to the target genes of these miRNAs. Furthermore, a protein-protein interaction (PPI) network was constructed, which revealed the involvement of the PPI-extracted hub genes in the regulation of proliferation and apoptosis. In conclusion, we propose that these types of miRNAs can be considered as the potential cancer therapy options for better induction of ICD in combination with other ICD inducers.
科研通智能强力驱动
Strongly Powered by AbleSci AI